Axalta Q3 Adjusted EBITDA Falls 4% to $282M; FY26 Guidance Set at $1.10-$1.11B
AXTA sits 37% above its 52-week low of $24.937.
Summary
Axalta reported Q3 2026 net sales of $1.3 billion (up 2%) but Adjusted EBITDA of $282 million (down 4%) and Adjusted Diluted EPS of $0.63 (down 6%), and guided full-year 2026 Adjusted EBITDA to $1,100-$1,110 million.
Key Events · Earnings and Guidance · AXTA
-
Q3 Sales Grow 2%, Profit Falls
Net sales of $1.311 billion rose 2% year over year, but net income fell $15 million to $95 million as merger and acquisition-related costs rose $14 million to $19 million in the quarter.
-
Adjusted EBITDA Down 4%
Adjusted EBITDA of $282 million produced a 21.5% margin versus 22.8% a year ago, with Performance Coatings segment Adjusted EBITDA down to $188 million from $211 million on European volume weakness.
-
Mobility Sets Quarterly Record
Mobility Coatings net sales reached a record $493 million, up 7%, and segment Adjusted EBITDA hit a third-quarter record $94 million with 100 basis points of margin expansion.
-
FY26 Guidance: $1.10-$1.11B EBITDA
Full-year 2026 Adjusted EBITDA is guided to $1,100-$1,110 million and Adjusted Diluted EPS to about $2.45, with Q4 Adjusted EBITDA of $254-$264 million and roughly flat net sales.
Analysis · AXTA · Industrial Applications And Services
The quarter was softer than a year ago: Adjusted EBITDA of $282 million fell 4% and Adjusted Diluted EPS of $0.63 dropped 6%, as lower Performance Coatings volumes in Europe and higher raw material and freight costs offset record Mobility Coatings sales of $493 million. Margins still held above 20%, and total net leverage of 2.1x marked the lowest in company history, while free cash flow rose 3% to $92 million. What matters now is the new full-year outlook: $1,100-$1,110 million in Adjusted EBITDA and roughly $2.45 in Adjusted Diluted EPS. That frames the earnings base shareholders are trading for AkzoNobel shares in the pending all-share merger of equals. Roughly $80 million of merger-related cash costs are baked into the ~$450 million free cash flow target, so the deal is already weighing on reported profitability.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 31% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AXTA was trading at $34.10 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $24.94 to $38.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.